Serum Creatinine as a Potential Biomarker of Skeletal Muscle Atrophy in Non-small Cell Lung Cancer Patients

Objectives: Identifying simple biomarkers to determine muscle atrophy in non-small-cell lung cancer (NSCLC) patients remains a critical research gap. Since creatinine is mainly a product from intramuscular creatine metabolism, we tested the hypothesis that low serum creatinine levels would be associ...

Descripción completa

Detalles Bibliográficos
Autores principales: das Neves, Willian, Alves, Christiano R. R., de Souza Borges, Ana Paula, de Castro, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072336/
https://www.ncbi.nlm.nih.gov/pubmed/33912068
http://dx.doi.org/10.3389/fphys.2021.625417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072336/
https://www.ncbi.nlm.nih.gov/pubmed/33912068
http://dx.doi.org/10.3389/fphys.2021.625417

Ejemplares similares